Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SENESCO TECHNOLOGIES INC | 3,679,797 | reported | 13 May 2021 | tx 11+6,395,925 |
| 89bio, Inc. | 1,134,671 | reported | 13 Nov 2019 | tx 3+1,134,671−5,500,001 |
| LB PHARMACEUTICALS INC | 411,681 | reported | 12 Sept 2025 | tx 3+1,411,681−10,000,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Sept 2025 | CONVERSION | LB PHARMACEUTICALS INC | 411,681 | — | |
| 12 Sept 2025 | PURCHASE | LB PHARMACEUTICALS INC | 1,000,000 | 15.00 USD | first after silence |
| 12 Sept 2025 | CONVERSION | LB PHARMACEUTICALS INC | 10,000,000 | — | deriv |
| 13 May 2021 | PURCHASE | SENESCO TECHNOLOGIES INC | 592,592 | 1.35 USD | |
| 13 May 2021 | PURCHASE | SENESCO TECHNOLOGIES INC | 1,422,222 | 1.35 USD | |
| 13 May 2021 | PURCHASE | SENESCO TECHNOLOGIES INC | 2,630,487 | 1.35 USD | first after silence |
| 13 May 2021 | PURCHASE | SENESCO TECHNOLOGIES INC | 1,280,624 | 1.35 USD | |
| 13 Nov 2019 | CONVERSION | 89bio, Inc. | 884,671 | — | |
| 11 Nov 2019 | PURCHASE | 89bio, Inc. | 250,000 | 16.00 USD | first after silence |
| 13 Nov 2019 | CONVERSION | 89bio, Inc. | 5,500,001 | 0.00 USD | deriv |
| 29 May 2019 | GRANT_AWARD | SENESCO TECHNOLOGIES INC | 20,000 | 0.00 USD | deriv |
| 29 May 2019 | GRANT_AWARD | SENESCO TECHNOLOGIES INC | 20,000 | 0.00 USD | deriv |
| 15 Jun 2018 | GRANT_AWARD | SENESCO TECHNOLOGIES INC | 40,000 | 0.00 USD | deriv |
| 15 Jun 2018 | GRANT_AWARD | SENESCO TECHNOLOGIES INC | 40,000 | 0.00 USD | deriv |
| 30 Apr 2018 | PURCHASE | SENESCO TECHNOLOGIES INC | 93,333 | 9.75 USD | |
| 30 Apr 2018 | PURCHASE | SENESCO TECHNOLOGIES INC | 84,041 | 9.75 USD | |
| 30 Apr 2018 | PURCHASE | SENESCO TECHNOLOGIES INC | 172,626 | 9.75 USD |
3 purchases reported after at least 12 months of silence — most recent on 12 Sept 2025.